Difference between revisions of "Urothelium"
m (→Where to start: mitoses) |
m (note about terminology) |
||
Line 1: | Line 1: | ||
The '''urothelium''' lines the upper portion of the genitourinary tract... and a bit of the lower part. | The '''urothelium''' lines the upper portion of the genitourinary tract... and a bit of the lower part. | ||
==Extent== | ==Extent of urothelium== | ||
===Urethra in males=== | ===Urethra in males=== | ||
*Pre-prostatic urethra - transistional epithelium. | *Pre-prostatic urethra - transistional epithelium. | ||
Line 27: | Line 27: | ||
#Round structures should make you think of papillae and prompt looking for fibrovascular cores. | #Round structures should make you think of papillae and prompt looking for fibrovascular cores. | ||
#Fibrovascular cores = papillae... may be cancer! | #Fibrovascular cores = papillae... may be cancer! | ||
==Note about terminology== | |||
*The bladder is rather unique in that "carcinoma" is a label used for things that are non-invasive. | |||
**It has been suggested that many things that are called ''papillary urothelial carcinoma'', would be better described as ''papillary intraurothelial neoplasia''.<ref name=pmid19160695>{{Cite journal | last1 = Van der Kwast | first1 = TH. | last2 = Zlotta | first2 = AR. | last3 = Fleshner | first3 = N. | last4 = Jewett | first4 = M. | last5 = Lopez-Beltran | first5 = A. | last6 = Montironi | first6 = R. | title = Thirty-five years of noninvasive bladder carcinoma: a plea for the use of papillary intraurothelial neoplasia as new terminology. | journal = Anal Quant Cytol Histol | volume = 30 | issue = 6 | pages = 309-15 | month = Dec | year = 2008 | doi = | PMID = 19160695 }}</ref> | |||
**If the terminology in the urinary bladder were applied to the colon, we'd call all ''adenomas'', i.e. pre-malignant lesions, ''carcinomas''. | |||
==Approach== | ==Approach== |
Revision as of 03:38, 20 June 2010
The urothelium lines the upper portion of the genitourinary tract... and a bit of the lower part.
Extent of urothelium
Urethra in males
- Pre-prostatic urethra - transistional epithelium.
- Prostatic urethra - transistional epithelium.
- Membranous urethra (from apex of prostate to bulb of penis (bulb of the corpus spongiosusm)) - pseudostrat. columnar epithelium.
- Spony urethra - pseudostratified columnar epi. (proximal) & strat. squamous (distal).
Normal histology
- Prominent nucleoli (???).
- Maturation (cuboidal at base - squamoid at surface).
- Surface cells called 'umbrella cells' (umbrella cells CK20+).
- Urothelium should be 4-5 cell layers thick.
- Should NOT have papillary architecture -- if it does it is likely cancer!
- If it is 'papillary' -- it must have fibrovascular cores.
Where to start
July 1st PGY-2:
- Urothelial carcinoma - essentially defined by increased nuclear size +/- irreg. nuclear contour.
- Nucleoli are common in urothelium.
- This can be confusing... prostate carcinoma has nucleoli.
- Mitosis - these are key if the nuclear enlargement is not present.[1]
- Cell-depleted urothelium, where the cells have shed-off--but a few remain, should raise suspicions to cancer.
- Thickness of the urothelium, otherwise, isn't very useful for diagnosing cancer.
- Nucleoli are common in urothelium.
- Round structures should make you think of papillae and prompt looking for fibrovascular cores.
- Fibrovascular cores = papillae... may be cancer!
Note about terminology
- The bladder is rather unique in that "carcinoma" is a label used for things that are non-invasive.
- It has been suggested that many things that are called papillary urothelial carcinoma, would be better described as papillary intraurothelial neoplasia.[2]
- If the terminology in the urinary bladder were applied to the colon, we'd call all adenomas, i.e. pre-malignant lesions, carcinomas.
Approach
- Papillary structure - with fibrovascular cores?
- Nuclear pleomorphism?
- Yes - high grade (4-5x lymphocyte) --> Dx: high grade papillary urothelial carcinoma
- No - low grade or normal (2-3x lymphocyte) --> DDx: low grade papillary urothelial carcinoma, PUNLMP, papilloma
- Nuclear pleomorphism?
- Flat lesions?
- Nuclear pleomorphism?
- Maturation to surface?
- No --> Dx: sectioning artefact vs. flat UCC.
- Yes --> likely benign.
- Normal thickness?
- normal is 4-5 cell layers.
- Nests of glandular cells
- consider cystitis cystica, cystitis glandularis, Brunn's nest, inverted papilloma.
- Inflammation?
- Michaelis-Gutman bodies?
Pitfalls:
- Urothelial carcinoma of the bladder may be confused with a paraganglioma of the bladder.
- Way to differentiate: paraganglioma = stippled chromatin, UCC = single nucleoli.
Risk factors for UCC
Risk factors for UCC:
Premalignant/Hyperplasic/Reactive changes
Several different benign/premalignant diagnoses can be made:
- Reactive atypia.
- Flat urothelial hyperplasia.
- Urothelial dysplasia.
Cancer
- Urothelial carcinoma in situ.
- Invasive UCC.
Comparison urothelial changes - flat epithelium - benign/premalignant/cancerous:[5]
Normal | Reactive atypia | Flat urothelial hyperplasia | Urothelial dysplasia | UCC in situ | Invasive UCC | |
Nuclear enlargement (X stromal lymphocyte) |
none (2x) | moderate, prominent (3x) | none (2x) | moderate (3x) | signif. (4-5x) | signif. (4-5X) |
Nucleoli | small | prominent | small | small, some multiple | +/-large | +/-large |
size var., shape | none, round | none, round | none, round | mod. variation, some irregularity | marked, irregular | marked, irregular |
Polarity | matures to surface | as normal | as normal | lost | lost | lost |
Mitoses | none/minimal | some, none atypical | as normal | rare, none atypical | common, atypical | common, atypical |
Thickness | 4-5 cells | as normal | increased | as normal | thin, thick or norm. | thin, thick or norm. |
Inflammation | none | severe, acute or chronic | usu. none | usu. none | +/- | +/- |
Other | - | - | - | - | - | stromal invasion |
The bold entry is considered the key feature.
Urothelial carcinoma in situ
Microscopic
- Nuclear changes (key feature).
- Enlargement of nuclei (often 4-5x the size of stromal lymphocytes) -- diagnostic.[6]
- Normal urothelium approx. 2x the size of stromal lymphocytes.
- Nuclear pleomorphism - marked variation in size of nuclei.
- Enlargement of nuclei (often 4-5x the size of stromal lymphocytes) -- diagnostic.[6]
- Disordered arrangement/crowding of cells.
- In normal urothelium the cell line-up on the basement membrane.
- Umbrella cells often absent.
- Mitoses present.
- +/-Enlarged nucleoli.
Urothelial cell carcinoma UCC (flat)
- Nuclear pleomorphism.
- Most important feature.
- Compare nuclei to one another.
- Increased N/C ratio.
- Lack of maturation to surface (important).
- Cells become dyscohesive.
- Mostly useless in my experience.
IHC
- CK7+ CK20+.
UCC vs. Prostate
- UCC: p63+, PSA-, PSAP-, CK7+, CK20+.
- Prostate: p63-, PSA+, PSAP+, CK7-, CK20-.
UCC (papillary lesions)
Papillary urothelial lesions are grouped into one of five categories (listed from bad to good prognosis):[7]
- High grade papillary.
- Low grade papillary.
- Papillary urothelial neoplasm of low malignant potential (PUNLMP).
- PUNLMP is pronouced "pun-lump".
- Inverted papilloma.
- Urothelial papilloma.
Key characteristics:
- Nuclear - size/pleomorphism.
- Papillae branching.
- Papillae fusion.
High grade papillary UCC
Micro.[7]
- "High grade nuclear features":
- Nuclear pleomorphism - often 4-5x the size of stromal lymphocytes.[8]
- Architectural complexity.
- Fused papillary common.
- Papillae branch.
- Mitoses common.
Low grade papillary UCC
Micro.[7]
- Fused papillae.
- Papillae branch.
- Larger nuclei than PUNLMPs.
PUNLUMP
Micro.[7]
- Rare fused papillae.
- Infrequent mitoses.
- Nuclei larger than papilloma - but monotonous.[9]
Papilloma
Micro.[7]
- Papillary fronds.
- Minimal branching or fusion.
- Cytological features of normal urothelium.
- Normal urothelium approx. 2x the size of stromal lymphocytes.[10]
- No mitoses.
Inverted papilloma
- Like papillomas... but grow downward.[7]
Tabular comparison of papillary lesions
Urothelial cells in papillae - benign/premalignant/cancerous:[11]
Papilloma | PUNLMP | low grade PUCC | high grade PUCC | |
papillae features | fat papillae, thick FV core |
slender FV core | slender FV core, thick epithelium |
mixed population |
papillae branching | rare | uncommon | frequent | common |
papillae fusion | none | rare | some | common |
nuclear size | normal (2x lymphocyte) | enlarged - uniform | enlarged with variation | 4-5x lymphocyte, marked pleomorphism |
mitoses | very rare basal | rare basal only | infreq., usually basal | common, everywhere |
DDx | PUNLMP, low gr. PUCC | papilloma, low gr. | PUNLMP, high gr. | low gr., invasive UCC |
IHC | p53-, CK20+ umbrella cells | CK20+ umbrella | -/+ p53, CK20+ umbrella | diffuse CK20+, p53+ in 50% |
Other | cytologically normal | low cellular density (@ low power) vs. low gr.[12] | +/- small nucleoli | nucleoli prominent |
Key feature | normal cells, fat papillae |
uniformly enlarged cell pop., slender papillae |
nuc. pleomorphism, thick epithelium |
marked nuclear pleomorphism |
Notes:
- FV core = fibrovascular core.
- PUCC = papillary urothelial carcinoma.
Benign
Brunn nests:[13]
- Benign inbudding nests of urothelium.
- Should lead to consideration of "inverted papilloma".
Cystitis cystica:[14]
- Brunn nests with urothelium.
cystitis glandularis:[15]
- Brunn nests with cuboidal and columnar epithelium.
Invasive UCC
Staging:
- T1 - lamina propria.
- Several subdivisions of T1 exist:[16]
- T1a - superficial or in muscularis mucosae.
- T1b - beyond muscularis mucosae - into submucosa.
- Several subdivisions of T1 exist:[16]
- T2 - muscularis propria.
Invasion vs. in situ
Useful features - present in invasion:[17]
- Thin-walled vessels.
- Stromal reaction (hypercellularity).
- Retraction artefact around the tumour cell nests.
Renal cell carcinoma
Clinically, it may not be possible to differentiate renal pelvis UCC and RCC.
See also
References
- ↑ JS. 9 June 2010.
- ↑ Van der Kwast, TH.; Zlotta, AR.; Fleshner, N.; Jewett, M.; Lopez-Beltran, A.; Montironi, R. (Dec 2008). "Thirty-five years of noninvasive bladder carcinoma: a plea for the use of papillary intraurothelial neoplasia as new terminology.". Anal Quant Cytol Histol 30 (6): 309-15. PMID 19160695.
- ↑ PMID 16413342.
- ↑ URL: http://content.nejm.org/cgi/content/full/343/17/1268. Accessed on: 27 May 2010.
- ↑ GUP PP.155-163
- ↑ GUP P.161.
- ↑ 7.0 7.1 7.2 7.3 7.4 7.5 WMSP P.310
- ↑ GUP P.161.
- ↑ GUP P.170.
- ↑ GUP P.161.
- ↑ GUP PP.166-175 and WMSP P.310
- ↑ GAG. 26 February 2009.
- ↑ PBoD P.1028.
- ↑ PBoD P.1028.
- ↑ PBoD P.1028.
- ↑ Sternberg, H4P 4th Ed., P.2048-9.
- ↑ Sternberg, H4P, P.2047.